Notice to Extend Expiration Date for PAR-20-129: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
Notice Number:
NOT-OD-22-086

Key Dates

Release Date:

March 14, 2022

Related Announcements

PAR-20-129 - SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)

Issued by

Office of The Director, National Institutes of Health (OD)

Purpose

The purpose of this Notice is to extend the expiration date for Funding Opportunity Announcement (FOA), PAR-20-129 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed).” PAR-20-129 will now expire on April 6, 2023. Future years amounts are contingent upon reauthorization and extension of the Commercialization Readiness Pilot (CRP) program.

The following key dates modification is as follows:

Currently Reads:

Part 1. Overview Information

Key Dates

Scientific Merit Review

Standard dates apply

Advisory Council Review

Standard dates apply

Earliest Start Date

Standard dates apply

Expiration Date

April 06, 2022

Due Dates for E.O. 12372

Not Applicable

Part 2. Full Text of Announcement

Section II. Award Information

Funds Available and Anticipated Number of Awards:

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

NIH is permitted to allocate not more than 10% of its overall SBIR funds allocated to the CRP program.

Modified to Read (change shown in bold italics):

Part 1. Overview Information

Key Dates

Scientific Merit Review

Standard dates apply

Advisory Council Review

Standard dates apply

Earliest Start Date

Standard dates apply

Expiration Date

April 06, 2023

Due Dates for E.O. 12372

Not Applicable

Part 2. Full Text of Announcement

Section II. Award Information

Funds Available and Anticipated Number of Awards:

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Future year amounts are contingent upon reauthorization and extension of the Commercialization Readiness Pilot (CRP) program.

NIH is permitted to allocate not more than 10% of its overall SBIR funds allocated to the CRP program.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

SEED (Small business Education and Entrepreneurial Development)

Office of Extramural Research

301-435-2688

SEEDinfo@nih.gov